Biopharmaceutical firm Pardes Biosciences plans to spend a large chunk of the funds it raised through a public offering late last month on a pill it is developing to treat Covid-19, including on …
( read original story …)
The Japan News
Biopharmaceutical firm Pardes Biosciences plans to spend a large chunk of the funds it raised through a public offering late last month on a pill it is developing to treat Covid-19, including on …
( read original story …)